… It illustrates that all patients start at 65 years old with non-valvular atrial fibrillation (NVAF) …
the odds ratio for ischemic stroke between the different oral anticoagulants. Dabigatran means …

… The consequences of AF included in the model were ischaemic stroke, intracranial haemorrhage,
… Incremental cost-effectiveness ratios and cost-effectiveness acceptability curves were …

Full article: Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and
Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-…

… , myocardial infarction, ischemic stroke, intracerebral hemorrhage… cost-effectiveness of
DOACs compared with warfarin in South Korean non-valvular AF patients with intermediate stroke …

… al 18 claimed superior cost-effectiveness of apixaban versus … the cost-effectiveness of DOACs
for stroke prevention among … Case fatality rate for ischemic stroke and hemorrhagic stroke …

… oral anticoagulants was compared with vitamin K antagonist for stroke prevention in patients
with non-valvular … The split between minor and major ischaemic stroke was derived from …

… A Markov model simulating the lifetime course of patients diagnosed with non-valvular
AF was used to evaluate the cost-effectiveness of DOACs (ie, rivaroxaban, dabigatran and …

… cost effectiveness of non-vitamin K oral anticoagulants (NOACs) compared with warfarin
for stroke prevention in patients with non-valvular … key clinical events: ischemic stroke (IS), …

… (DOACs) have been preferred anticoagulants due to favourable efficacy, … cost-effectiveness
of DOACs compared to warfarin with varying anticoagulation controls for stroke prevention …

… cost-effectiveness of LAAC with the Watchman device relative to warfarin and direct oral
anticoagulants (DOACs) for stroke … with non-valvular AF (NVAF) have an annual ischemic stroke …